Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Louisiana Patients Could Lose Access to GLP-1 Weight-Loss Drugs as Coverage Vanishes Highlights Louisiana state employees are already prohibited from using GLP-1s for weight loss despite $200 million annual spending on diabetes coverage Over 41 million Americans lost commercial insurance coverage for Wegovy in 2026, with major insurers eliminating coverage nationwide Four states, including California and Pennsylvania, eliminated Medicaid coverage for obesity treatment between October 2025 and January 2026 Louisiana Medicaid provides limited coverage for one non-GLP-1 weight-loss drug but restrictions remain tight Patients face monthly costs ranging from $936 to $1,349 without insurance coverage BATON ROUGE, La
Worth noting Contains EU-listed fragrance allergens, including Lavandula Angustifolia Extract and Linalool
Why is oral glutathione often ineffective
To understand these weight loss drugs, we need to step back and look at their history
According to the recent findings from Harvard economist Rebecca Diamond in her June 2026 National Bureau of Economic Research working paper, GLP-1Induced Weight Loss and the Female Obesity Penalty, women who were not employed when they began taking GLP-1 medications for weight loss experienced a significant change in their employment prospects after 18 months of usage
US$ 29.47
US$ 26.52
US$ 26.08
US$ 29.25
